title: Thienopyridine and cilostazol are safer for gastroduodenal mucosa than low-dose aspirin--second report of endoscopic evaluation.
authors.forename: Takatsugu
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Tadahisa
authors.initials: T
authors.lastname: Ebato
authors.forename: Yuji
authors.initials: Y
authors.lastname: Mishina
authors.forename: Koichiro
authors.initials: K
authors.lastname: Abe
authors.forename: Kengo
authors.initials: K
authors.lastname: Hattori
authors.forename: Taro
authors.initials: T
authors.lastname: Ishii
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Kuyama
mesh_terms: D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000077407:Cilostazol; D004724:Endoscopy; D005260:Female; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000473:pathology; D008297:Male; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D013777:Tetrazoles; D000077407:Cilostazol; D001241:Aspirin